Stability of cidofovir in 0.9% sodium chloride injection for five days.
Ennis
R D
RD
Department of Formulation and Process Development, Gilead Sciences, Inc., Foster City, CA 94404, USA.
Dahl
T C
TC
D000998:Antiviral Agents / Q000737:chemistry*; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000737:chemistry; D004355:Drug Stability; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000737:chemistry*; D011095:Polyethylenes / Q000737:chemistry; D011126:Polypropylenes / Q000737:chemistry; D011143:Polyvinyl Chloride / Q000737:chemistry; D012965:Sodium Chloride; D012996:Solutions; D013696:Temperature
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011095:Polyethylenes; D011126:Polypropylenes; D012996:Solutions; D012965:Sodium Chloride; D003596:Cytosine; D011143:Polyvinyl Chloride; D000077404:Cidofovir